MINNEAPOLIS, Oct. 20, 2011 /PRNewswire/ -- Miromatrix Medical Inc. announced today that former Minnesota Governor Timothy Pawlenty was elected to its Board of Directors at the company's October 17 board meeting.
"I am extremely excited to join the board of a company that has the potential to improve human health in an historic way within its reach," Pawlenty stated. "In my view, Miromatrix likely will be Minnesota's next medical and business miracle," he added.
The Miromatrix Medical technology was created to enable the creation of fully biological replacement organs for the human body. In addition to the company's internal efforts focused on the development of its first producta biomesh for hernia repair and breast reconstructionscientists around the globe are working with Miromatrix's technology and are taking the first steps toward the creation of human organs including the liver, lung, kidney, pancreas and heart.
Miromatrix has enjoyed significant support and cooperation from both the State of Minnesota and the University of Minnesota. The town of Glencoe, Minn., recently joined this list of supporters by attracting the company to its industrial park, where Miromatrix will move into a new laboratory constructed to its specifications within the facility of one of its primary suppliers.
"We are thrilled to have someone of Governor Pawlenty's caliber join our Board of Directors," said Robert Cohen, Miromatrix President & CEO. "We look forward to his advice and counsel as we pursue commercial products and strategic relationships with our game-changing technology," Cohen added.
Miromatrix Medical Inc. is a regenerative medicine company engaged in the development of commercial products based upon its perfusion decellularization/recellularization technology licensed from the University of Minnesota.
Contact: Robert Cohen
Miromatrix President & CEO
(612) 202-7026
rcohen@miromatrix.com
SOURCE Miromatrix Medical Inc.
